New Zealand markets closed

Fate Therapeutics, Inc. (FATE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.7000-0.2100 (-5.37%)
At close: 04:00PM EDT
3.7000 0.00 (0.00%)
After hours: 07:59PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-190,051
-160,928
-281,721
-212,151
-173,387
-
Depreciation & amortisation
18,912
18,282
13,758
5,850
3,087
-
Stock-based compensation
43,457
43,459
78,733
54,364
30,753
-
Change in working capital
7,644
19,182
-34,710
2,098
-12,773
-
Accounts receivable
12,642
36,654
-29,804
-3,160
-5,515
-
Other working capital
-139,784
-138,416
-283,774
-213,574
-44,161
-
Other non-cash items
-4,981
-40,860
-24,012
-18,098
111,415
-
Net cash provided by operating activities
-136,753
-132,263
-248,208
-162,870
-39,229
-
Cash flows from investing activities
Investments in property, plant and equipment
-3,031
-6,153
-35,566
-50,704
-4,932
-
Purchases of investments
-330,693
-358,810
-404,796
-968,159
-277,344
-
Sales/maturities of investments
454,363
477,628
607,113
694,840
121,200
-
Net cash used for investing activities
120,639
112,665
166,751
-324,023
-161,076
-
Cash flows from financing activities
Debt repayment
-
-
-
0
0
-15,000
Common stock issued
-
-
0
411,735
272,693
162,406
Common stock repurchased
-
-
-
-
-
0
Other financing activities
-
-
-
-
490
-
Net cash used provided by (used for) financing activities
95,366
85
9,207
453,129
282,838
-
Net change in cash
79,252
-19,513
-72,250
-33,764
82,533
-
Cash at beginning of period
57,247
76,560
148,810
182,574
100,041
-
Cash at end of period
136,499
57,047
76,560
148,810
182,574
-
Free cash flow
Operating cash flow
-136,753
-132,263
-248,208
-162,870
-39,229
-
Capital expenditure
-3,031
-6,153
-35,566
-50,704
-4,932
-
Free cash flow
-139,784
-138,416
-283,774
-213,574
-44,161
-